Certificate of Competence in Breast Cancer - fourth cohort (CCB4)
04.05.2021 - 23.07.2022
APPLICATION CLOSED
POSTGRADUATE PROGRAMME
Block 3
01.08.2021 - 30.09.2021
CCB4: Module 2: Principles of diagnostics, DCIS, gene predisposition
Programme
1 August | ||
| 0:00 | Principles of standard diagnostics (mammography, ultrasound, MRI) Francesca Caumo, IT | |
| 0:00 | New radiological techniques Julia Camps Herrero, ES | |
| 0:00 | Breast cancer screening Nehmat Houssami, AU | |
| 0:00 | Interventional radiology: Lymphoscintigraphy, ROLL; MRI-guided biopsy Pietro Panizza, IT | |
| 0:00 | Diagnostic challenges in young women and during pregnancy Tanja Gagliardi, UK | |
| 0:00 | To stage or not to stage: Conventional staging, PET/CT Elzbieta Senkus, PL | |
| 0:00 | DCIS: Radiological assessment Dragana Djilas, RS | |
| 0:00 | DCIS: Pathology classification and margins Tibor Tot, SE | |
| 0:00 | DCIS: Surgical challenges Lynda Wyld, UK | |
| 0:00 | DCIS: The role of radiotherapy Youlia Kirova, FR | |
| 0:00 | DCIS: The role of medical treatment Mangesh Thorat, UK | |
| 0:00 | Genetic predisposition assessment and management Helen Hanson, UK | |
Faculty
Julia Camps Herrero, Hospital de la Ribera, Dept. of Radiology, Alzira, ES
Francesca Caumo, Istituto Oncologico Veneto, Imaging Dpt., Padova, IT
Dragana Djilas, Oncology Institute of Vojvodina, Diagnostic Imaging Centre, Sremska Kamenica, RS
Tanja Gagliardi, Royal Marsden Hospital, Radiology Dpt., London, UK
Helen Hanson, St Georges NHS Foundation Trust, South West Thames Regional Genetics Service, London, UK
Nehmat Houssami, University of Sydney, Sydney Medical School, Sydney, AU
Youlia Kirova, Institut Curie, Radiation Oncology Dpt., Paris, FR
Pietro Panizza, Segrate, IT
Elzbieta Senkus, Medical University of Gdansk, Dept. of Oncology and Radiotherapy, Gdansk, PL
Mangesh Thorat, Wolfson Institute of Preventive Medicine, Queen Mary University of London, Dept. of Cancer Prevention, London, UK
Tibor Tot, Dalarna Region County Hospital, Dept of Pathology and Cytology, Falun, SE
Lynda Wyld, University of Sheffield, Dept. of Oncology, Sheffield, UK



